WallStreetZenWallStreetZen

NASDAQ: IMCR
Immunocore Holdings Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Immunocore Holdings revenue was $310.20M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $84.1M, up 4.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IMCR annual revenue was $310.2M, with 24.4% growth year-over-year.

IMCR past revenue growth

How has IMCR's revenue growth performed historically?

Company
24.37%
Industry
437.31%
Market
20.27%
IMCR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IMCR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
IMCR's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

IMCR revenue history

Current Revenue
$310.2M
Current Earnings
-$51.1M
Current Profit Margin
-16.5%

Be the first to know when IMCR announces revenue.

IMCR Revenue History By Year

IMCR Yearly RevenueIMCR RevenueIMCR ChangeIMCR Revenue Growth
2024-12-31$310.20M$60.77M+24.37%
2023-12-31$249.43M$75.07M+43.05%
2022-12-31$174.36M$137.88M+377.91%
2021-12-31$36.48M-$1.16M-3.08%
2020-12-31$37.64M$5.56M+17.32%
2019-12-31$32.09M$2.52M+8.52%
2018-12-31$29.57MN/AN/A

1 of 1

Immunocore Holdings Revenue FAQ

What was IMCR's revenue last quarter?

On Invalid Date, Immunocore Holdings (NASDAQ: IMCR) reported Q4 2024 revenue of $84.05 million up 19.8% year over year. In the same quarter last year, Immunocore Holdings's revenue was $70.16 million.

What was Immunocore Holdings's revenue in 2024?

Immunocore Holdings's annual revenue for the twelve months ending Dec 31, 2024 was $310.20 million, a 24.37% increase year over year.

How much does Immunocore Holdings make in a day?

Based on Immunocore Holdings annual revenue for the past five years, IMCR makes an average of $442,804.11 per day.

What was Immunocore Holdings's annual revenue growth in the past year?

As of Q2 2025, Immunocore Holdings's revenue has grown 24.37% year over year. This is 412.94 percentage points lower than the US Biotechnology industry revenue growth rate of 437.31%. Immunocore Holdings's revenue in the past year totaled $310.20 million.

How much does Immunocore Holdings make in a year?

Immunocore Holdings's revenue by year for the past five years is:
  • Immunocore Holdings's revenue for the twelve months ending Dec 31, 2024 was $310.20 million, a 24.37% increase year over year.
  • Immunocore Holdings's annual revenue for Dec 31, 2023 was $249.43 million, a 43.05% increase from 2022.
  • Immunocore Holdings's annual revenue for 2022 was $174.36 million, a 377.91% increase from 2021.
  • Immunocore Holdings's annual revenue for 2021 was $36.48 million, a 3.08% decrease from 2020.
  • Immunocore Holdings's annual revenue for 2020 was $37.64 million, a 17.32% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.